234 related articles for article (PubMed ID: 26155840)
1. Efficacy and safety of oral branched-chain amino acid supplementation in patients undergoing interventions for hepatocellular carcinoma: a meta-analysis.
Chen L; Chen Y; Wang X; Li H; Zhang H; Gong J; Shen S; Yin W; Hu H
Nutr J; 2015 Jul; 14():67. PubMed ID: 26155840
[TBL] [Abstract][Full Text] [Related]
2. Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.
Hayaishi S; Chung H; Kudo M; Ishikawa E; Takita M; Ueda T; Kitai S; Inoue T; Yada N; Hagiwara S; Minami Y; Ueshima K
Dig Dis; 2011; 29(3):326-32. PubMed ID: 21829025
[TBL] [Abstract][Full Text] [Related]
3. [Effect of oral administration of branched-chain amino acids supplementation on the mortality of patients with hepatocellular carcinoma: a meta-analysis].
Xue WX; Yang F; Duan JJ; Sun JB; Peng H
Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(47):3793-3800. PubMed ID: 33379845
[No Abstract] [Full Text] [Related]
4. Effects of branched-chain amino acid supplementation after radiofrequency ablation for hepatocellular carcinoma: A randomized trial.
Nojiri S; Fujiwara K; Shinkai N; Iio E; Joh T
Nutrition; 2017 Jan; 33():20-27. PubMed ID: 27908546
[TBL] [Abstract][Full Text] [Related]
5. Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial.
Poon RT; Yu WC; Fan ST; Wong J
Aliment Pharmacol Ther; 2004 Apr; 19(7):779-88. PubMed ID: 15043519
[TBL] [Abstract][Full Text] [Related]
6. Systematic review with meta-analysis: Branched-chain amino acid supplementation in liver disease.
van Dijk AM; Bruins Slot AS; Portincasa P; Siegerink SN; Chargi N; Verstraete CJR; de Bruijne J; Vleggaar FP; van Erpecum KJ
Eur J Clin Invest; 2023 Mar; 53(3):e13909. PubMed ID: 36394355
[TBL] [Abstract][Full Text] [Related]
7. Oral supplementation with carbohydrate- and branched-chain amino acid-enriched nutrients improves postoperative quality of life in patients undergoing hepatic resection.
Okabayashi T; Iyoki M; Sugimoto T; Kobayashi M; Hanazaki K
Amino Acids; 2011 Apr; 40(4):1213-20. PubMed ID: 20852905
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of early interventional therapy of branched-chain amino acid granules in patients with hepatocellular carcinoma: propensity score matching analysis.
Nishikawa H; Kita R; Kimura T; Ohara Y; Takeda H; Sakamoto A; Saito S; Nishijima N; Nasu A; Komekado H; Osaki Y
Int J Oncol; 2014 Sep; 45(3):1082-90. PubMed ID: 24969042
[TBL] [Abstract][Full Text] [Related]
9. Importance of branched-chain amino acids in patients with liver cirrhosis and advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
Kanekawa T; Nagai H; Kanayama M; Sumino Y
Cancer Chemother Pharmacol; 2014 Nov; 74(5):899-909. PubMed ID: 25138286
[TBL] [Abstract][Full Text] [Related]
10. Branched-chain amino acids as pharmacological nutrients in chronic liver disease.
Kawaguchi T; Izumi N; Charlton MR; Sata M
Hepatology; 2011 Sep; 54(3):1063-70. PubMed ID: 21563202
[TBL] [Abstract][Full Text] [Related]
11. Supplementation of branched-chain amino acids maintains the serum albumin level in the course of hepatocellular carcinoma recurrence.
Kakazu E; Kondo Y; Kogure T; Ninomiya M; Kimura O; Iwata T; Morosawa T; Iwasaki T; Shimosegawa T
Tohoku J Exp Med; 2013 Aug; 230(4):191-6. PubMed ID: 23892757
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of Levocarnitine and/or Branched-Chain Amino Acids during Invasive Treatment for Hepatocellular Carcinoma.
Iwasa M; Sugimoto R; Ishihara T; Sekoguchi-Fujikawa N; Yoshikawa K; Mifuji-Moroka R; Tanaka H; Kobayashi Y; Hasegawa H; Takei Y
J Nutr Sci Vitaminol (Tokyo); 2015; 61(6):433-40. PubMed ID: 26875483
[TBL] [Abstract][Full Text] [Related]
13. Branched-chain amino acids prevent hepatocarcinogenesis and prolong survival of patients with cirrhosis.
Kawaguchi T; Shiraishi K; Ito T; Suzuki K; Koreeda C; Ohtake T; Iwasa M; Tokumoto Y; Endo R; Kawamura NH; Shiraki M; Habu D; Tsuruta S; Miwa Y; Kawaguchi A; Kakuma T; Sakai H; Kawada N; Hanai T; Takahashi S; Kato A; Onji M; Takei Y; Kohgo Y; Seki T; Tamano M; Katayama K; Mine T; Sata M; Moriwaki H; Suzuki K
Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1012-8.e1. PubMed ID: 24036055
[TBL] [Abstract][Full Text] [Related]
14. Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: a prospective randomized trial. The San-in Group of Liver Surgery.
Br J Surg; 1997 Nov; 84(11):1525-31. PubMed ID: 9393270
[TBL] [Abstract][Full Text] [Related]
15. Effects of branched-chain amino acids supplementation on patients undergoing hepatic intervention: a meta-analysis of randomised controlled trials.
Hsu YM; Kuan HC; Chen YA; Chiu CW; Chen PC; Tam KW
Br J Nutr; 2024 Jan; 131(2):276-285. PubMed ID: 37642137
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids.
Shimizu M; Shirakami Y; Hanai T; Imai K; Suetsugu A; Takai K; Shiraki M; Moriwaki H
Mol Nutr Food Res; 2014 Jan; 58(1):124-35. PubMed ID: 24273224
[TBL] [Abstract][Full Text] [Related]
17. The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation.
Nishikawa H; Osaki Y; Iguchi E; Koshikawa Y; Ako S; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Sakamoto A; Henmi S; Hatamaru K; Ishikawa T; Saito S; Nasu A; Kita R; Kimura T
J Clin Gastroenterol; 2013 Apr; 47(4):359-66. PubMed ID: 23090049
[TBL] [Abstract][Full Text] [Related]
18. Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study.
Park JG; Tak WY; Park SY; Kweon YO; Chung WJ; Jang BK; Bae SH; Lee HJ; Jang JY; Suk KT; Oh MJ; Heo J; Woo HY; Jang SY; Lee YR; Lee JS; Kim DY; Kim SH; Suh JI; Kim IH; Kang MK; Lee WK
Nutrients; 2020 May; 12(5):. PubMed ID: 32429077
[TBL] [Abstract][Full Text] [Related]
19. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma.
Takeshita S; Ichikawa T; Nakao K; Miyaaki H; Shibata H; Matsuzaki T; Muraoka T; Honda T; Otani M; Akiyama M; Miuma S; Ozawa E; Fujimito M; Eguchi K
Nutr Res; 2009 Feb; 29(2):89-93. PubMed ID: 19285598
[TBL] [Abstract][Full Text] [Related]
20. Impact of the branched-chain amino acid to tyrosine ratio and branched-chain amino acid granule therapy in patients with hepatocellular carcinoma: A propensity score analysis.
Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Yama T
J Gastroenterol Hepatol; 2015 Sep; 30(9):1412-9. PubMed ID: 25799910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
